Vor Biopharma (VOR) Retained Earnings (2020 - 2026)
Vor Biopharma's (VOR) quarterly Retained Earnings came in at -$1.4 billion in Q1 2026, down 180.42% year-on-year from $1.7 billion in Q1 2025, and down 3347904.88% on a QoQ basis from $41000.0 in Q4 2025.
Vor Biopharma (VOR) Retained Earnings (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Retained Earnings data on file, last reported at -$1.4 billion in Q1 2026.
- On a quarterly basis, Retained Earnings fell 180.42% year-over-year to -$1.4 billion in Q1 2026; TTM through Mar 2026 was -$1.4 billion, a 180.42% decrease from a year earlier, with the FY2025 full-year figure at $41000.0, up 86.36% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.4 billion, down from $41000.0 in the prior quarter.
- Over the last five years, Retained Earnings for VOR reached as high as $41000.0 in Q4 2025 and fell as low as -$2.9 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$522.4 million across 5 years, with a median of -$222.2 million in 2022.
- Across the five-year window, Retained Earnings jumped 100.01% in 2024 and plunged 2947185.71% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$222.2 million in 2022, then slumped by 53.04% to -$340.1 million in 2023, then soared by 100.01% to $22000.0 in 2024, then soared by 86.36% to $41000.0 in 2025, then plunged by 3347904.88% to -$1.4 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$1.4 billion in Q1 2026, $41000.0 in Q4 2025, and -$2.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | -1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.37 Bn |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | -2.88 Bn |
| Jun 30, 2025 | -2.06 Bn |
| Mar 31, 2025 | -489.48 Mn |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -426.28 Mn |
| Jun 30, 2024 | -70,000.00 |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -340.08 Mn |
| Sep 30, 2023 | -313.82 Mn |
| Jun 30, 2023 | -436,000.00 |
| Mar 31, 2023 | -250.65 Mn |
| Dec 31, 2022 | -222.22 Mn |
| Sep 30, 2022 | -198.31 Mn |
| Jun 30, 2022 | -174.52 Mn |
| Mar 31, 2022 | -152.86 Mn |
| Dec 31, 2021 | -130.12 Mn |
| Sep 30, 2021 | -111.87 Mn |
| Jun 30, 2021 | -93.32 Mn |